NewGenIvf (NIVF) Notes Payables (2024 - 2025)
NewGenIvf (NIVF) posted Notes Payables of $256056.0 for Q4 2025, up 210.57% on a QoQ basis from $82447.0 in Q4 2024, and up 210.57% year-over-year from $82447.0 in Q4 2024.
NewGenIvf (NIVF) has 2 years of Notes Payables data on file, last reported at $256056.0 in Q4 2025.
- In Q4 2025, Notes Payables rose 210.57% year-over-year to $256056.0; the TTM figure through Dec 2025 stood at $256056.0 (up 210.57% YoY), while the FY2025 annual figure was $256056.0, up 210.57% from the prior year.
- Notes Payables advanced to $256056.0 in Q4 2025, from $82447.0 in the prior quarter.
- Across five years, Notes Payables topped out at $256056.0 in Q4 2025 and bottomed at $82447.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | NewGenIvf | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 256,056.00 |
| Dec 31, 2024 | 82,447.00 |